We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FGMC:NASDAQFG Merger II Corp. Analysis

Data as of 2026-05-26 - not real-time

$10.33

Latest Price

3/10Risk

Risk Level: Low

Executive Summary

FG Merger II Corp. (FGMC) is trading at $10.33, barely below the 52‑week high of $10.34 and hugging the calculated resistance of $10.34 while sitting just above the technical support of $10.14. The stock shows a bullish technical backdrop – the 20‑day SMA ($10.25) sits above the 50‑day SMA ($10.17), the MACD line is positive and crossing its signal, and the RSI is at an elevated 77.7, indicating overbought momentum. Volume is on an increasing trend, and the beta is essentially neutral (≈0), suggesting low market‑wide price sensitivity, while 30‑day volatility is modest at 2.86%.
Fundamentally, the picture is starkly different: FGMC reports zero revenue, no earnings, and a trailing EPS of $0.12, resulting in an astronomically high PE of 86× and a PB of 272×. The discounted cash‑flow model values the company at roughly $1.36 per share, implying a massive overvaluation of the current price. The firm has no dividend and a negative free cash flow, and its only catalyst is the pending merger with BOXABL, a modular housing company, which remains uncertain and untested. Consequently, the stock’s upside is driven more by speculative merger hopes than by intrinsic financial strength.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Pending BOXABL merger provides near‑term catalyst
  • Technical overbought conditions and proximity to resistance
  • Extreme valuation gap versus DCF fair value

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Uncertainty around merger completion and post‑merger integration
  • Continued lack of revenue and earnings
  • Low beta and modest volatility reduce market‑risk exposure

Long Term

> 3 years
Cautious
Model confidence: 4/10

Key Factors

  • Fundamental fundamentals remain nil with no sustainable cash flow
  • Valuation remains far above any realistic intrinsic value
  • Absence of dividend and high PE/PB ratios limit long‑term attractiveness

Key Metrics & Analysis

Financial Health

P/E Ratio86.1
ROE737.66%
ROA-1.47%
P/B Ratio271.8
Op. Cash Flow$1.5M
Free Cash Flow$-434147
Industry P/E16.8

Technical Analysis

TrendBullish
RSI77.7
Support$10.14
Resistance$10.34
MA 20$10.25
MA 50$10.17
MA 200$10.06
MACDBullish
VolumeIncreasing
Fear & Greed Index91.64

Valuation

Fair Value$1.36
GradeOvervalued
TypeGrowth

Risk Assessment

Beta-0.00
Volatility2.85%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.